|
UBE3A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.47019999999921E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.297540E-02 |
| Normal-vs-Stage2 |
2.944600E-01 |
| Normal-vs-Stage3 |
5.34270000018822E-07 |
| Normal-vs-Stage4 |
2.01369999996981E-06 |
| Stage1-vs-Stage2 |
7.423400E-01 |
| Stage1-vs-Stage3 |
4.839700E-04 |
| Stage1-vs-Stage4 |
2.017900E-03 |
| Stage2-vs-Stage3 |
3.298300E-02 |
| Stage2-vs-Stage4 |
3.598100E-02 |
| Stage3-vs-Stage4 |
9.493400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.026100E-04 |
| Normal-vs-AfricanAmerican |
3.74610000000164E-05 |
| Normal-vs-Asian |
1.652220E-01 |
| Caucasian-vs-AfricanAmerican |
7.844500E-02 |
| Caucasian-vs-Asian |
9.851400E-01 |
| AfricanAmerican-vs-Asian |
5.056200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.52651999999476E-05 |
| Normal-vs-Female |
1.976340E-02 |
| Male-vs-Female |
2.367700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.952500E-04 |
| Normal-vs-Age(41-60Yrs) |
5.798700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.436430E-04 |
| Normal-vs-Age(81-100Yrs) |
9.818000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.324190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.059200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.195000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.087800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.877600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.867200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.919600E-01 |
| Normal-vs-Grade 2 |
1.523800E-01 |
| Normal-vs-Grade 3 |
4.36039999995863E-07 |
| Normal-vs-Grade 4 |
3.06349945411455E-10 |
| Grade 1-vs-Grade 2 |
4.586600E-01 |
| Grade 1-vs-Grade 3 |
6.917700E-03 |
| Grade 1-vs-Grade 4 |
1.376230E-04 |
| Grade 2-vs-Grade 3 |
4.05639999999652E-05 |
| Grade 2-vs-Grade 4 |
1.4658000035972E-08 |
| Grade 3-vs-Grade 4 |
1.158050E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.747200E-01 |
| Normal-vs-ccB subtype |
1.4440000000171E-06 |
| ccA subtype-vs-ccB subtype |
1.47650000004163E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.804740E-03 |
| Normal-vs-N1 |
2.834000E-02 |
| N0-vs-N1 |
2.062600E-01 |
|
|
